Cargando…
Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules
BACKGROUND: To evaluate clinical outcomes of stereotactic body radiotherapy (SBRT) for localized primary and oligometastatic lung tumors by assessing efficacy and safety of 5 regimens of varying fraction size and number. METHODS: One-hundred patients with primary lung cancer (n = 69) or oligometasta...
Autores principales: | Aoki, Masahiko, Hatayama, Yoshiomi, Kawaguchi, Hideo, Hirose, Katsumi, Sato, Mariko, Akimoto, Hiroyoshi, Fujioka, Ichitaro, Ono, Shuichi, Tsushima, Eiki, Takai, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719671/ https://www.ncbi.nlm.nih.gov/pubmed/26791943 http://dx.doi.org/10.1186/s13014-016-0581-2 |
Ejemplares similares
-
Prognostic impact of average iodine density assessed by dual-energy spectral imaging for predicting lung tumor recurrence after stereotactic body radiotherapy
por: Aoki, Masahiko, et al.
Publicado: (2016) -
Impact of low iodine density tumor area ratio on the local control of non-small cell lung cancer through stereotactic body radiotherapy
por: Tanaka, Mitsuki, et al.
Publicado: (2021) -
Safe and successful birth following pelvic radiotherapy for rectal mucosa-associated lymphoid tissue lymphoma: a case report
por: Hatayama, Yoshiomi, et al.
Publicado: (2017) -
Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study
por: Aoki, Masahiko, et al.
Publicado: (2016) -
Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54–56 Gy given in 9–7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size
por: Aoki, Masahiko, et al.
Publicado: (2015)